objective: nonalcoholic fatty liver disease (nafld) is the most common form of liver disease in the world and it is one of the liver transplantation causes. the present study aimed to investigate the effect of purslane seeds on anthropometric parameters, fasting blood glucose (fbs), and liver enzymes in patients with nonalcoholic fatty livers. materials and methods: in this clinical trial, 54 p...

results the relative expression of mtdna copy number was 3.7 fold higher in nafld patients than healthy controls (p < 0.0001). the results remained significant after adjustment for age, bmi, and gender (p = 0.02). in addition, the mtdna copy number was 4.3 (p < 0.0001) and 3.2-fold (p < 0.0001) higher in nonalcoholic fatty liver (nafl) and non-alcoholic steatohepatitis (nash) patients than heal...

background: we tested whether hepatic haemodynamics assessed by doppler ultrasonography can be a predictor of response to therapy in patients with non‑alcoholic fatty liver disease (nafld) to prevent further unnecessary diagnostic tests and interventions. methods: forty eight consecutive patients affected by nafld, who refered to some clinics in tabriz, iran between 2009 and 2011 were included ...

conclusions considering the significant decrease in the liver enzymes, triglycerides and cholesterol after using berberis vulgaris extract, further studies with larger sample sizes will identify the accurate dose as well as duration of consumption for this extract, to recommend in the treatment of patients with nafld. results in the case group, the mean serum levels of alanine transaminase (alt...

conclusions saturated fatty acids (sfas) served as a potential ligand for tlr4 and activated tlr4 signaling pathway, which might be involved in the pathogenesis. thus, sfas can accelerate the mechanism of inhibiting hbv replication in chb with nafld. objectives this study aimed to investigate whether the tlr4-mediated innate immunity stimulates the pathogenesis of chb in patients with nafld and...

BACKGROUND Nonalcoholic fatty liver disease has become a worldwide challenge. Liver biopsy remains the single most reliable approach to determine the severity of this disease. As patients with nonalcoholic fatty liver disease require close follow-up, performing this invasive method repeatedly seems impractical; therefore, designing a noninvasive system to follow up patients has become a common ...